• Irinotecan for Colorectal Cancer: Mechanistic Depth & Transl

  2026-05-09

  Explore the unique mechanistic profile of Irinotecan (CPT-11) in colorectal cancer research. This article delivers a deeper analysis of DNA damage, apoptosis pathways, and translational applications, offering actionable perspectives for advanced oncology workflows.

• Berberine Modulates RXRα/PPARγ/NEDD4 to Suppress SASP in Ath

  2026-05-08

  This study demonstrates that berberine inhibits senescence-associated secretory phenotype (SASP)–driven inflammation in atherosclerotic models by activating the RXRα/PPARγ/NEDD4 pathway. These findings highlight new mechanistic insights into anti-inflammatory interventions targeting cellular senescence in cardiovascular disease.

• Irinotecan (CPT-11): Protocols for Colorectal Cancer Researc

  2026-05-08

  Irinotecan (CPT-11) is a benchmark tool in colorectal cancer research, enabling precise studies of DNA damage, apoptosis, and in vivo tumor suppression. This article delivers actionable, evidence-based workflows and troubleshooting strategies to maximize reproducibility and data quality in cell-based and xenograft assays.

• Dual-Action p38α MAPK Inhibitors: Mechanisms and Implication

  2026-05-07

  This article analyzes a recent study demonstrating that certain p38α MAP kinase inhibitors not only block kinase activity but also enhance dephosphorylation by stabilizing a phosphatase-accessible conformation. These dual-action mechanisms offer new avenues for specificity and efficacy in kinase-targeted research, with particular relevance for inflammation, apoptosis, and type 1 diabetes models.

• Medroxyprogesterone Acetate: Optimizing Decidualization Mode

  2026-05-07

  Medroxyprogesterone acetate (MPA) is a synthetic progestin powering advanced models in reproductive, renal, and neurobiology research. This guide details robust workflows, protocol refinements, and troubleshooting approaches for maximizing assay fidelity with MPA—translating recent mechanistic insights into practical laboratory advantages.

• Sumatriptan Succinate: Advanced 5-HT1 Receptor Agonist Workf

  2026-05-06

  Sumatriptan Succinate, a selective 5-HT1 receptor agonist, is redefining migraine and neuroinflammation research with its dual action on vascular and immune pathways. This guide delivers actionable protocols, troubleshooting insights, and comparative context for maximizing experimental rigor using APExBIO’s high-purity standard.

• Enhancing Luteolin Bioavailability via P-gp Efflux Inhibitio

  2026-05-06

  This study introduces a self-microemulsifying drug delivery system (SME) for luteolin, utilizing P-glycoprotein (P-gp) efflux inhibition to dramatically enhance oral bioavailability. The approach demonstrates mechanistic innovation by integrating D-α-tocopheryl polyethylene glycol 1000 succinate as a P-gp inhibitor, achieving a 29-fold increase in systemic luteolin exposure with strong biosafety, and offers translational potential for improving the delivery of poorly absorbed bioactive compounds.

• RWJ 67657 in Inflammatory Disease Research: Precision with J

  2026-05-05

  RWJ 67657 (JNJ-3026582) delivers selective, dual-action inhibition of p38α/β MAP kinases, setting a new standard for dissecting TNF-alpha-driven inflammatory pathways. This guide demystifies its application in cytokine modulation assays, highlights advanced troubleshooting, and translates structural insights into actionable protocols.

• DNase I (RNase-free): Optimizing 3D Co-Culture and RNA Workf

  2026-05-05

  Unlock robust DNA removal for advanced 3D organoid-fibroblast and RNA-centric assays with DNase I (RNase-free). This guide translates recent tumor microenvironment research into actionable protocol enhancements, troubleshooting, and strategic workflow insights.

• Medroxyprogesterone Acetate: Applied Protocols in Cell & Dis

  2026-05-04

  Medroxyprogesterone acetate (MPA) from APExBIO empowers advanced workflows in hormone signaling, renal physiology, and endometrial biology. This article distills proven protocols, troubleshooting insights, and novel findings—optimizing research from renal collecting duct epithelial cell assays to endometriosis models.

• Palonosetron Hydrochloride in the Prevention of CINV: Clinic

  2026-05-04

  This review highlights the clinical innovation of palonosetron hydrochloride, a next-generation 5-HT3 receptor antagonist, in reducing chemotherapy-induced nausea and vomiting (CINV). The article focuses on pharmacologic advantages, comparative efficacy, and the implications for oncology research, particularly in the context of regimens involving agents like irinotecan.

• Medroxyprogesterone Acetate in Decidualization & Renal Model

  2026-05-03

  Medroxyprogesterone acetate (MPA) delivers unmatched reliability in modeling hormone-driven differentiation, renal epithelial signaling, and neuroendocrine modulation. This guide unpacks applied workflows, troubleshooting, and the latest cross-domain insights to supercharge research fidelity with APExBIO’s trusted reagent.

• Brain-to-Spinal Circuits Modulate Mechanical Allodynia Later

  2026-05-02

  Huo et al. (2023) elucidate descending neural pathways from the brain to spinal cord that regulate both the side-specificity and persistence of mechanical allodynia in mice. By mapping a multisynaptic circuit involving parabrachial, hypothalamic, and spinal components, the study advances understanding of how bilateral pain hypersensitivity is limited, with implications for opioid receptor pharmacology and pain modulation research.

• Minoxidil Sulphate: Protocols and Innovations in Vascular Bi

  2026-05-01

  Minoxidil sulphate, the active metabolite of minoxidil, is redefining vascular and hair growth research with its high purity and robust potassium channel activation. This guide delivers actionable workflows, troubleshooting, and data-backed insights—translating a pivotal reference study into practical protocols for reproducible, high-impact results.

• 4-Hydroxytamoxifen: Technical Guidance for Laboratory Resear

  2026-05-01

  4-Hydroxytamoxifen offers a high-purity, DMSO-soluble estrogen receptor modulator for protocols in breast and prostate cancer research, as well as studies on cardiac myocyte calcium handling. This reagent should not be used in workflows requiring aqueous or ethanol solubility and demands strict storage for reproducibility.

15572 records 1/1039 page Next 12345 下5页 Last page